Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 2
Submit an article Journal homepage
5
Views
1
CrossRef citations to date
0
Altmetric
Articles

Glycoprotein IIIa gene polymorphism and coronary artery disease

Alp AydinalpDept. of Cardiology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.Correspondence[email protected]
, MD,
Ilyas AtarDept. of Cardiology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, MD,
Fatma Belgin AtacDept. of Medical Biology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, PhD,
Ayse Canan YaziciDept. of Biostatistics, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, PhD,
Mutlu CicekDept. of Cardiology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, MD,
Mustafa YilmazDept. of Cardiology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, MD,
Aliseydi OzgulDept. of Cardiology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, MD,
Asli AtarDept. of Cardiology, Güven Hospital, Ankara, Turkey.
, MD,
Mehmet Emin KorkmazDept. of Cardiology, Güven Hospital, Ankara, Turkey.
, MD,
Bülent ÖzinDept. of Cardiology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, MD &
Haldun MüderrisogluDept. of Cardiology, Baskent University, Faculty of Medicine, Ankara Hospital, Ankara, Turkey.
, MD show all
Pages 225-230 | Received 07 Jul 2009, Published online: 23 May 2017

References

  • Mikkelsson J, Perola M, Laippala P, Savolainen V, Pajarinen J, Lalu K, Penttild A, Karhunen PI Glycoprotein lIla P1(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 1999; 19: 2573–8.
  • Nurden AT. Platelet glycoprotein Ma polymorphism and coronary thrombosis. Lancet 1997; 350: 1189–91.
  • Goldschmidt-Clermont PJ, Roos CM, Cooke GE. Platelet P1A2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics. J Thromb Thrombolysis 1999; 8: 89–103.
  • Ridker PM, Hennekens CH, Schmitz C, Stampfer MJ, Lindpaintner K. PIA1/A2 polymorphism of platelet glyco-protein Ma and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385–8.
  • Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harrington RA, Krumholz HM, Simoons ML, Van de Werf FJ, Weintraub WS, Mitchell KR, Mor-risson SL, Brindis RG, Anderson HV, Cannom DS, Chit-wood WR, Cigarroa JE, Collins-Nakai RL, Ellis SG, Gibbons RJ, Grover FL, Heidenreich PA, Khandheria BK, Knoebel SB, Krumholz HL, Malenka DJ, Mark DB, Mckay CR, Passamani ER, Radford MJ, Riner RN, Schwartz JB, Shaw RE, Shemin RJ, Van Fossen DB, Verrier ED, Watkins MW, Phoubandith DR, Fumelli T. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Car-diol 2001; 38: 2114–30.
  • Kiechle FL. DNA technology, the clinical laboratory, and the future. Arch Pathol Lab Med 2001; 125: 72–6.
  • Rossi ML, Merlini PA. Role of GP IIb/IIIa blockers in clinical cardiology. Recenti Frog Med 2003; 94: 440–3 [in Italian].
  • van Goor ML, Gómez Garcia E, Brouwers GJ, Leebeek FW, Koudstaal PJ, Dippel DW. PLA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIa in young patients with cryptogenic TIA or ischemic stroke. Thromb Res 2002; 108: 63–5.
  • Wagner KR, Giles WH, Johnson CJ, Ou CY, Bray PF, Gold-schmidt-Clermont PJ, Croft JB, Brown VK, Stern BJ, Feeser BR, Buchholz DW, Earley CJ, Macko RF, McCarter RJ, Sloan MA, Stolley PD, Wityk RJ, Wozniak MA, Price TR, Kittner SJ. Platelet glycoprotein receptor Ma polymorphism P1 A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study. Stroke 1998; 29: 581–5.
  • Lagercrantz J, Bergman M, Lundman P, Tornvall P, Hjem-dahl P, Hamsten A, Eriksson P. No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein Ma is implicated in angiographically characterized coronary ath-erosclerosis and premature myocardial infarction. Blood Coagul Fibrinolysis 2003; 14: 749–53.
  • Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, Carlquist JF. Associations between a polymor-phism in the gene encoding glycoprotein Ma and myocar-dial infarction or coronary artery disease. J Am Coll Cardiol 1999; 33: 727–33.
  • Mikkelsson J, Perola M, Laippala P. Penttild A, Karhunen PJ. Glycoprotein lIla P1 (Al /A2) polymorphism and sudden cardiac death. J Am Coll Cardiol 2000; 36: 1317–23.
  • Carter AM, Ossei-Gerning N, Wilson IJ, Grant PJ. Associ-ation of the platelet P1 (A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 1997; 96: 1424–31.
  • Zhu MM, Weedon J, Clark LT. Meta-analysis of the asso-ciation of platelet glycoprotein lila Pl(A1)/A2 polymorphism with myocardial infarction. Am J Cardiol 2000; 86: 1000–5.
  • Grove EL, Orntoft TF, Lassen JF, Jensen HK, Kristensen SD. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med 2004; 255: 637–44.
  • Melus V, Pullmann R, Hybenova J, Skerenova M, Pullmann R Jr. Is PLA1/A2 gene polymorphism of platelet membrane glycoprotein Ma a risk factor for myocardial infarct? Bratisl Lek Listy 1999; 100: 593-97 [in Slovak].
  • Benze G, Heinrich J, Schulte H, Rust S, Nowak-Göttl U, Tataru MC, Köhler E, Assmann G, Junker R. Association of the GPIa C807T and GPIIIa PIA 1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J 2002; 23: 325–30.
  • Wiwanitkit V. PIA1 /A2 polymorphism of the platelet glyco-protein receptor IIb/IIIIa and its correlation with myocardial infarction: an appraisal. Clin Appl Thromb Hemost 2006; 12: 93–5.
  • Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: implications of aspirin resistance. J Am Coll Cardiol 2008; 51: 1829–43.
  • Le Hello C, Morello R, Lequerrec A, Duarte C, Riddell J, Hamon M. Effect of PlAl /A2 glycoprotein Ma gene poly-morphism on the long-term outcome after successful coro-nary stenting. Thromb J 2007; 19: 1–8.
  • Kastrati A, Koch W, Gawaz M, Mehilli J, Böttiger C, Schömig K, von Beckerath N, Schtimig A. PIA polymorphism of glyco-protein Ma and risk of adverse events after coronary stent placement. J Am Coll Cardiol 2000; 36: 84–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.